JPH064651B2 - Phosphate ester and method for producing the same - Google Patents
Phosphate ester and method for producing the sameInfo
- Publication number
- JPH064651B2 JPH064651B2 JP61181653A JP18165386A JPH064651B2 JP H064651 B2 JPH064651 B2 JP H064651B2 JP 61181653 A JP61181653 A JP 61181653A JP 18165386 A JP18165386 A JP 18165386A JP H064651 B2 JPH064651 B2 JP H064651B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- mol
- hydrogen atom
- represented
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 Phosphate ester Chemical class 0.000 title claims description 38
- 229910019142 PO4 Inorganic materials 0.000 title description 4
- 238000004519 manufacturing process Methods 0.000 title description 4
- 239000010452 phosphate Substances 0.000 title description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 150000003863 ammonium salts Chemical class 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 20
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- 238000000921 elemental analysis Methods 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 150000003014 phosphoric acid esters Chemical class 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 150000003904 phospholipids Chemical class 0.000 description 11
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- HUZDEBHITBCSDA-INIZCTEOSA-N (2s)-2-[benzyl(phenylmethoxycarbonyl)amino]-3-hydroxypropanoic acid Chemical compound C=1C=CC=CC=1COC(=O)N([C@@H](CO)C(O)=O)CC1=CC=CC=C1 HUZDEBHITBCSDA-INIZCTEOSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 4
- JKAZBSJEALXCFY-UHFFFAOYSA-N 2-amino-15-phosphonooxypentadecanoic acid Chemical compound NC(CCCCCCCCCCCCCOP(O)(O)=O)C(=O)O JKAZBSJEALXCFY-UHFFFAOYSA-N 0.000 description 4
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 108010003541 Platelet Activating Factor Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000003541 multi-stage reaction Methods 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- UUWJHAWPCRFDHZ-UHFFFAOYSA-N 1-dodecoxydodecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC UUWJHAWPCRFDHZ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- ZPDQFUYPBVXUKS-YADHBBJMSA-N 1-stearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OC[C@H](N)C(O)=O ZPDQFUYPBVXUKS-YADHBBJMSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- AMPNHXDCSLIYEU-UHFFFAOYSA-N 2-amino-5,5,6,6,7,7,8,8,9,9,10,10,11,11-tetradecafluoro-11-phosphonooxy-4-(2,2,2-trifluoroethyl)undecanoic acid Chemical compound NC(CC(C(C(C(C(C(C(C(F)(F)OP(O)(O)=O)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)CC(F)(F)F)C(=O)O AMPNHXDCSLIYEU-UHFFFAOYSA-N 0.000 description 1
- RUWOTBASWCAIML-UHFFFAOYSA-N 2-hydroxyhexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCC(O)COP(O)(O)=O RUWOTBASWCAIML-UHFFFAOYSA-N 0.000 description 1
- XJONADGJIULCPD-UHFFFAOYSA-N 2-octyldodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCC(COP(O)(O)=O)CCCCCCCC XJONADGJIULCPD-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- QZLLPBQCTVQQIQ-UHFFFAOYSA-N P(O)(O)(O)=O.C(CCCCCCCCCCC)OCC(OCCCCCCCCCCCCCCCCCC)CC(C(=O)O)N Chemical compound P(O)(O)(O)=O.C(CCCCCCCCCCC)OCC(OCCCCCCCCCCCCCCCCCC)CC(C(=O)O)N QZLLPBQCTVQQIQ-UHFFFAOYSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 125000003901 ceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 125000000755 henicosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002818 heptacosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000002463 lignoceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 125000002819 montanyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001802 myricyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000002465 nonacosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UHGIMQLJWRAPLT-UHFFFAOYSA-N octadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCCCOP(O)(O)=O UHGIMQLJWRAPLT-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 125000002460 pentacosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000002469 tricosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は新規なリン酸エステル、更に詳細には、置換基
としてセリンまたはその塩を有するリン酸エステルに関
する。TECHNICAL FIELD The present invention relates to a novel phosphoric acid ester, and more particularly to a phosphoric acid ester having serine or a salt thereof as a substituent.
従来、同一分子内にアミノ基またはアンモニウム基等の
窒素を含む極性基を有するリン酸エステルとしては、天
然のホスファチジルコリン、ホスファチジルエタノール
アミン、ホスファチジルセリン及びスフィンゴ脂質等に
代表されるリン脂質がよく知られている。これらのリン
脂質は同一分子内に疎水基と親水基の両者を有し、表面
活性、乳化性等の界面活性を有するため多方面にわたっ
て使用されている。Conventionally, phospholipids typified by natural phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine and sphingolipids are well known as phosphoric acid esters having a polar group containing nitrogen such as amino group or ammonium group in the same molecule. ing. These phospholipids have both a hydrophobic group and a hydrophilic group in the same molecule and have surface activity such as surface activity and emulsifying property, and are therefore used in various fields.
また、これらのリン脂質は以前から生物の細胞内に多量
に存在し、生体膜を構成している主な成分であることが
知られており、近年これらのリン脂質が生体において単
に生体膜構成成分としてのみ存在するのではなく、種々
の重要な生理作用を行っていることが徐々に解明されて
きている。例えば、ホスファチジルコリンに類似した構
造を有するエーテル型リン脂質のひとつである血小板活
性化因子(PAF)は極めて微量で血圧降下作用や溶血作
用及び免疫活性作用等を示すことが明らかになってい
る。また、ホスファチジルセリンは、生体内でジグリセ
リドやカルシウムイオン共存下でアデノシン三リン酸
(ATP)非依存性のリン酸化酵素であるプロティンキナ
ーゼCを活性化して種々の生命活動に関与していること
も判明しつつある。更にホスファチジルセリンの2位の
アシル基を加水分解して得られるリゾホスファチジルセ
リンがアレルギー反応等に関与していることも解明され
つつある。In addition, it has been known for a long time that these phospholipids are abundant in the cells of living organisms and are the main constituents of biological membranes. In recent years, these phospholipids simply constitute biological membranes in living organisms. It has been gradually elucidated that it does not exist only as a component but has various important physiological actions. For example, it has been clarified that platelet activating factor (PAF), which is one of ether type phospholipids having a structure similar to phosphatidylcholine, exhibits an antihypertensive action, a hemolytic action, an immunoreactive action and the like in an extremely small amount. In addition, phosphatidylserine is also involved in various life activities by activating protein kinase C, which is an adenosine triphosphate (ATP) -independent phosphatase in the presence of diglyceride and calcium ions in vivo. It is becoming clear. Further, it is becoming clear that lysophosphatidylserine obtained by hydrolyzing the 2-acyl group of phosphatidylserine is involved in allergic reaction and the like.
従ってこのような生物活性を有するこれらのリン脂質と
構造が類似する物質、すなわち同一分子内にアミノ基ま
たはアンモニウム基等の窒素を含有する極性基を有する
リン酸エステルも種々の活性や機能を有することが予想
され、アミノ基等の窒素を含む極性基を含有するリン脂
質の類似体で安価かつ容易に入手可能な原料を使用し、
簡単な操作で高純度のものが合成可能なリン酸エステル
の開発が望まれていた。Therefore, substances having a structure similar to those phospholipids having such biological activity, that is, phosphates having a polar group containing nitrogen such as amino group or ammonium group in the same molecule also have various activities and functions. It is expected that, using a cheap and easily available raw materials in analogs of phospholipids containing polar groups containing nitrogen such as amino groups,
It has been desired to develop a phosphoric acid ester that can be synthesized with high purity by a simple operation.
しかしながら、一般にリン脂質の合成はきわめて困難で
あり、その合成は多くの場合多段階の反応を必要とする
ため、目的とする化合物は低収率でしか得られない〔例
えば、イー・ベア(E.Baer)ら、ジャーナル・オブ・ザ
・アメリカン・ケミカル・ソサイエティー(J.Amer.Che
m.Soc.)72,942(1950)、山川民夫編「脂
質」共立出版(1973)〕。However, in general, the synthesis of phospholipids is extremely difficult, and the synthesis often requires multistep reactions, so that the target compound can be obtained only in a low yield [for example, e. .Baer) et al., Journal of the American Chemical Society (J.Amer.Che.
m.Soc.) 72 , 942 (1950), edited by Tamio Yamakawa, "Lipid" Kyoritsu Shuppan (1973)].
また、リン脂質と類似の構造を有するリン酸エステルの
合成研究もいくつか報告されているが、それらの方法は
多段階の反応が必要であったり、また合成が困難な原料
を必要としたり、あるいは反応後の目的生成物の分離が
困難な場合が少なくなく、また収率も低く、しかも得ら
れる化合物の特性も十分ではないことが多い(例えば特
公昭42-23330号、特公昭48-1654号、米国特許3507937
号)。In addition, some synthetic studies of phosphoric acid esters having a structure similar to phospholipids have been reported, but those methods require multistep reactions, or require raw materials that are difficult to synthesize, Alternatively, it is often difficult to separate the target product after the reaction, the yield is low, and the properties of the obtained compound are often not sufficient (for example, JP-B-42-23330 and JP-B-48-1654). U.S. Pat.
issue).
斯かる実情において、本発明者らは鋭意検討を行った結
果、アミノ酸のひとつであるセリンを含有するリン脂質
であるホスファチジルセリンに類似したリン酸エステル
であり、安価かつ容易に入手可能な原料を使用し、簡単
な操作で高純度で合成可能なリン酸エステル及びその製
造方法を見出し、本発明を完成した。In such an actual situation, as a result of intensive investigations by the present inventors, a phosphoric acid ester similar to phosphatidylserine which is a phospholipid containing serine which is one of amino acids, and a raw material which is inexpensive and easily available The present invention has been completed by discovering a phosphoric acid ester which can be synthesized with high purity by a simple operation and a method for producing the same.
すなわち本発明は、次式(I) 〔式中、R1は次式(II) (式中、R4は炭素数8〜36の直鎖または分岐鎖の、水
素原子がフッ素原子で置換されていてもよいアルキル基
を、R5は水素原子、メチル基またはエチル基を、nは0
〜20の数を示す) で表わされるR2かまたは次式(III) (式中、R6はR7またはOR8で示され、R7、R8は炭素数8
〜36の直鎖または分岐鎖の、水素原子がフッ素原子で
置換されていてもよいアルキル基を示す) で表わされるR3を示し、M1及びM2は同じかまたは異なっ
て水素原子、アルカリ金属、またはアルカノールアミン
塩若しくはアンモニウム塩であることを示す〕 で表わされるリン酸エステルを提供するものである。更
にまた、本発明は、(I)式で表わされるリン酸エステル
を製造するための新規な製造方法を提供するものであ
る。That is, the present invention is the following formula (I) (Wherein, R 1 is the following formula (II) (In the formula, R 4 is a linear or branched alkyl group having 8 to 36 carbon atoms in which a hydrogen atom may be substituted with a fluorine atom, R 5 is a hydrogen atom, a methyl group or an ethyl group, and n is Is 0
R 2 or the formula represented by 20 the number of) (III) (In the formula, R 6 is represented by R 7 or OR 8 , and R 7 and R 8 have 8 carbon atoms.
~ 36 straight-chain or branched, which represents an alkyl group in which a hydrogen atom may be substituted with a fluorine atom) R 3 is represented by, and M 1 and M 2 are the same or different and each is a hydrogen atom, an alkali. It shows that it is a metal or an alkanolamine salt or an ammonium salt]. Furthermore, the present invention provides a novel production method for producing the phosphoric acid ester represented by the formula (I).
本発明のリン酸エステルにおいて、R4で表わされる炭素
数8〜36の直鎖または分岐鎖のアルキル基としては例
えば、オクチル、ノニル、デシル、ウンデシル、ドデシ
ル、トリデシル、テトラデシル、ペンタデシル、ヘキサ
デシル、ヘプタデシル、オクタデシル、ノナデシル、エ
イコシル、ヘンエイコシル、ドコシル、トリコシル、テ
トラコシル、ペンタコシル、ヘキサコシル、ヘプタコシ
ル、オクタコシル、ノナコシル、トリアコンチル、ヘン
トリアコンチル、ドトリアコンチル、トリトリアコンチ
ル、テトラトリアコンチル、ペンタトリアコンチル、ヘ
キサトリアコンチル、2−エチルヘキシル、2−ブチル
オクチル、2−ヘキシルデシル、2−ヘキシルドデシ
ル、2−エチルヘキサデシル、2−オクチルドデシル、
2−ブチルヘキサデシル、2−オクチルテトラデシル、
2−ヘキシルヘキサデシル、2−ブチルオクタデシル、
2−エチルエイコシル、2−デシルテトラデシル、2−
デシルヘキサデシル、2−ヘキシルエイコシル、2−エ
チルテトラエイコシル、2−ドデシルヘキサデシル、2
−テトラデシルオクタデシルまたは2−ヘキサデシルエ
イコシル、トリデカフルオロオクチル、ヘプタデカフル
オロデシル、ヘンエイコサフルオロドデシル、ペンタコ
サフルオロテトラデシル、ノナコサフルオロヘキサデシ
ル、トリトリアコンタフルオロオクタデシル、2−ペン
タフルオロエチルペンタフルオロヘキシル、2−トリデ
カフルオロヘキシルトリデカフルオロデシル、2−ヘプ
タデカフルオロオクチルヘプタデカフルオロドデシル、
2−ヘンエイコサフルオロデシルヘンエイコサフルオロ
テトラデシル、2−ペンタコサフルオロドデシルペンタ
コサフルオロヘキサデシル、2−ノナコサフルオロテト
ラデシルノナコサフルオロオクタデシル基等が挙げられ
る。またR5は水素原子、メチル基またはエチル基であ
る。また式(III)においてR6はR7またはOR8で示される
が、このR7及びR8としては、式(II)のR4と同じ置換基が
挙げられる。またM1、M2におけるアルカリ金属として
は、ナトリウム、カリウムが挙げられ、またアルカノー
ルアミンとしてはトリエタノールアミン等が挙げられ
る。In the phosphate ester of the present invention, examples of the linear or branched alkyl group having 8 to 36 carbon atoms represented by R 4 include octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl. , Octadecyl, nonadecyl, eicosyl, heneicosyl, docosyl, tricosyl, tetracosyl, pentacosyl, hexacosyl, heptacosyl, octacosyl, nonacosyl, triacontyl, gentriacontyl, dotriacontyl, tritriacontyl, tetratriacontyl, pentatriacontyl, hexatriacon Tyl, 2-ethylhexyl, 2-butyloctyl, 2-hexyldecyl, 2-hexyldecyl, 2-ethylhexadecyl, 2-octyldodecyl,
2-butylhexadecyl, 2-octyltetradecyl,
2-hexylhexadecyl, 2-butyloctadecyl,
2-ethyl eicosyl, 2-decyl tetradecyl, 2-
Decyl hexadecyl, 2-hexyl eicosyl, 2-ethyl tetraeicosyl, 2-dodecyl hexadecyl, 2
-Tetradecyl octadecyl or 2-hexadecyl eicosyl, tridecafluorooctyl, heptadecafluorodecyl, heneicosafluorododecyl, pentacosafluorotetradecyl, nonacosafluorohexadecyl, tritriacontafluorooctadecyl, 2-pentafluoro Ethyl pentafluorohexyl, 2-tridecafluorohexyl tridecafluorodecyl, 2-heptadecafluorooctyl heptadecafluorododecyl,
2-heneicosafluorodecyl heneicosafluorotetradecyl, 2-pentacosafluorododecyl pentacosafluorohexadecyl, 2-nonacosafluorotetradecyl nonacosafluorooctadecyl group and the like. R 5 is a hydrogen atom, a methyl group or an ethyl group. Further, in the formula (III), R 6 is represented by R 7 or OR 8 , and the R 7 and R 8 include the same substituents as R 4 in the formula (II). Examples of the alkali metal in M 1 and M 2 include sodium and potassium, and examples of the alkanolamine include triethanolamine.
本発明において式(I)で示されるリン酸エステルは、例
えば次に示す反応式に従って製造される。In the present invention, the phosphoric acid ester represented by the formula (I) is produced, for example, according to the reaction formula shown below.
(式中、R1は前記と同じ) すなわち、式(IV)で示されるモノアルキルリン酸1モル
に対し2〜10モルのハロゲンが発生可能な量の、例え
ばチオニルクロライド等のハロゲン化試薬とを、例えば
テトラヒドロフラン等のエーテル系、ノルマルヘキサン
等の炭化水素系またはクロロホルム、四塩化炭素等のハ
ロゲン系等の不活性な溶媒中または無溶媒中で0〜10
0℃、好ましくは40〜80℃で反応させることにより
式(VI)で示されるジハロホスホリデートを得る。 (In the formula, R 1 is the same as above.) That is, with a halogenating reagent such as thionyl chloride in an amount capable of generating 2 to 10 mol of halogen per 1 mol of the monoalkylphosphoric acid represented by the formula (IV). In an inert solvent such as an ether system such as tetrahydrofuran, a hydrocarbon system such as normal hexane or a halogen system such as chloroform and carbon tetrachloride, or in the absence of a solvent.
The dihalophosphoridate represented by the formula (VI) is obtained by reacting at 0 ° C, preferably 40 to 80 ° C.
次に式(VI)で示されるジハロホスホリデート1モルに対
し、式(V)で示されるN−ベンジルオキシカルボニルセ
リンエステル1〜5モル好ましくは1〜2モルとを、例
えばクロロホルム等の不活性溶媒中または無溶媒下で例
えばピリジンやキノリン等のアミン存在下0〜100
℃、好ましくは0〜50℃で反応させ、反応終了後反応
系中にジハロホスホリデートのハロゲンに対して過剰の
水を加えて加水分解することにより式(VII)で示される
リン酸エステルを得る。Next, with respect to 1 mol of the dihalophosphoridate represented by the formula (VI), 1 to 5 mol, preferably 1 to 2 mol, of the N-benzyloxycarbonyl serine ester represented by the formula (V) is added, for example, chloroform or the like. 0-100 in the presence of an amine such as pyridine or quinoline in an inert solvent or without a solvent
C., preferably 0 to 50.degree. C., and after the reaction is completed, the excess amount of water is added to the halogen of the dihalophosphoridate in the reaction system to cause hydrolysis, whereby the phosphoric ester of the formula (VII) is hydrolyzed. To get
最後に、得られた(VII)で示されるリン酸エステルを、
例えば酢酸/メタノール中白金またはパラジウム等の水
素化金属触媒を用いてメタノール還流温度で加熱するこ
とにより脱ベンジル化すれば式(I)で示されるリン酸エ
ステルを得ることができる。Finally, the obtained phosphate ester represented by (VII)
For example, by debenzylation by heating at a methanol reflux temperature using a metal hydride catalyst such as platinum or palladium in acetic acid / methanol, the phosphoric acid ester represented by the formula (I) can be obtained.
これらの化合物はシリカゲルカラムクロマトグラフィー
等の手段により不純物を分離除去することにより精製で
きる。These compounds can be purified by separating and removing impurities by means such as silica gel column chromatography.
叙上の如く、本発明のリン酸エステルは、リン脂質に類
似した構造を有し、同一分子内にアミノ基のごとき窒素
を含有する極性基を有するため、乳化能、保湿能等に優
れ、新しい乳化剤、保湿剤等として有用なものである。As described above, the phosphoric acid ester of the present invention has a structure similar to phospholipids and has a polar group containing nitrogen such as an amino group in the same molecule, and therefore has excellent emulsifying ability, moisturizing ability, etc. It is useful as a new emulsifier, moisturizer, etc.
また、本発明の製造方法によれば、このように優れた特
性を有するリン酸エステルを安価かつ高収率で得ること
ができる。Further, according to the production method of the present invention, a phosphoric acid ester having such excellent properties can be obtained at low cost and in high yield.
次に実施例を挙げて説明する。尚、本発明は以下の実施
例に限定されるものではない。Next, examples will be described. The present invention is not limited to the examples below.
実施例1 モノラウリルリン酸100.0g(0.38mol)とチオニ
ルクロライド134.4g(1.13mol)を反応器に入れ
50℃で窒素気流下で4時間加熱攪拌する。反応終了
後、クロロホルム100mを加え反応物を溶解させた
後、キノリン103.4g(0.80mol)を加えて攪拌す
る。この溶液をベンジル−N−ベンジルオキシカルボニ
ルセリン157.5g(0.46mol)を100mのクロ
ロホルムに溶解させ0℃まで冷却しておいた溶液に0℃
で窒素気流下で滴下する。0℃で4時間攪拌し、その後
室温にまで反応温度を上げ4時間攪拌する。反応終了
後、100mの水を加え20℃で1時間攪拌する。そ
の後溶媒を留去しジエチルエーテルで抽出する。得られ
たエーテル層を塩酸水溶液で洗浄した後、エーテルを留
去する。得られた残渣をメタノールに溶解しパラジウム
/炭素触媒を用いて常圧下メタノール加熱還流水素を吹
込み約10時間反応させた後、メタノールを留去し、得
られた残渣をシリカゲルカラムクロマトグラフィーによ
り精製した(展開溶媒/クロロホルム:メタノール=9
0:10)。得られた63.5gの白色固体を分析したと
ころ以下のような結果が得られ、本化合物が2−アミノ
−2−カルボキシエチル−ラウリルリン酸であることを
確認した(0.18mol、収率47.3%)。Example 1 100.0 g (0.38 mol) of monolauryl phosphoric acid and 134.4 g (1.13 mol) of thionyl chloride were placed in a reactor and heated and stirred at 50 ° C. under a nitrogen stream for 4 hours. After completion of the reaction, 100 m of chloroform is added to dissolve the reaction product, and then 103.4 g (0.80 mol) of quinoline is added and stirred. This solution was dissolved in 157.5 g (0.46 mol) of benzyl-N-benzyloxycarbonylserine in 100 m of chloroform and cooled to 0 ° C.
At a nitrogen stream. Stir at 0 ° C. for 4 hours, then raise the reaction temperature to room temperature and stir for 4 hours. After completion of the reaction, 100 m of water is added and the mixture is stirred at 20 ° C. for 1 hour. Then, the solvent is distilled off and the residue is extracted with diethyl ether. The obtained ether layer is washed with a hydrochloric acid aqueous solution, and then the ether is distilled off. The obtained residue is dissolved in methanol, and methanol is heated under reflux under normal pressure with a palladium / carbon catalyst. Hydrogen is blown thereinto for reaction for about 10 hours, then methanol is distilled off, and the obtained residue is purified by silica gel column chromatography. (Developing solvent / chloroform: methanol = 9
0:10). When the obtained 63.5 g of white solid was analyzed, the following results were obtained, and it was confirmed that this compound was 2-amino-2-carboxyethyl-lauryl phosphoric acid (0.18 mol, yield 47.3%).
リン酸エステルを分析したところ下記のような結果が得
られ、目的とするリン酸エステルであることを確認し
た。When the phosphoric acid ester was analyzed, the following results were obtained, and it was confirmed that the target phosphoric acid ester was obtained.
元素分析(重量%) 計算値 C:50.99、H:9.13、N:3.96、P:8.76 実測値 C:50.78、H:9.02、N:3.88、P:8.761 H-NMR(溶媒:CDCl3/CD3OD)第1図 δ:0.87(broad,s,3H) 1.27(broad,s,21H) 3.30(m,4H+MeOH) 3.60〜3.96(m,1H) IR(KBr)第2図 3420,2940,1670,1580,1520,1420,1030,990(cm-1) 実施例2 モノオクタデシルリン酸100.0g(0.29mol)とチ
オニルクロライド103.5g(0.87mol)を反応器に
入れ実施例1と同様の方法で反応する。反応終了後、実
施例1と同様の方法で51.4g(0.65mol)のピリジ
ンを加えて溶解させた溶液をベンジル−N−ベンジルオ
キシカルボニルセリン120.2g(0.35mol)をクロ
ロホルムに溶解させた溶液に実施例1と同様の方法で滴
下し、その後実施例1と同様の方法により67.3gの2
−アミノ−2−カルボキシエチル−オクタデシルリン酸
の白色固体を得た(0.15mol、収率53.0%)。Elemental analysis (% by weight) Calculated value C: 50.99, H: 9.13, N: 3.96, P: 8.76 Actual value C: 50.78, H: 9.02, N: 3.88, P: 8.76 1 H-NMR (solvent: CDCl 3 / CD 3 OD) Figure 1 δ: 0.87 (broad, s, 3H) 1.27 (broad, s, 21H) 3.30 (m, 4H + MeOH) 3.60〜3.96 (m, 1H) IR (KBr) Figure 2 3420, 2940,1670,1580,1520,1420,1030,990 (cm -1 ) Example 2 100.0 g (0.29 mol) of monooctadecylphosphoric acid and 103.5 g (0.87 mol) of thionyl chloride were put into a reactor. React in the same manner as in Example 1. After the reaction was completed, 51.4 g (0.65 mol) of pyridine was added and dissolved in the same manner as in Example 1 to dissolve a solution of benzyl-N-benzyloxycarbonylserine (120.2 g, 0.35 mol) in chloroform. The solution thus prepared was added dropwise in the same manner as in Example 1, and then 67.3 g of 2 was added in the same manner as in Example 1.
A white solid of -amino-2-carboxyethyl-octadecyl phosphate was obtained (0.15 mol, yield 53.0%).
元素分析(重量%) 計算値 C:57.64、H:10.14、N:3.20、P:7.08 実測値 C:57.60、H:10.19、N:3.07、P:6.99 実施例3 モノ(2−オクチルドデシル)リン酸100.0g(0.2
6mol)とチオニルクロライド79.8g(0.67mol)を
実施例1と同様の方法で反応させジクロロホスホリデー
トを得た。これを84.0g(0.65mol)のキノリンと
混合して得られた溶液をベンジル−N−ベンジルオキシ
カルボニルセリン107.8g(0.31mol)を溶解させ
たクロロホルム中0℃で滴下しその後実施例1と同様の
方法により目的とする2−アミノ−2−カルボキシエチ
ル−2−オクチルドデシルリン酸の白色固体58.8gを
得た(0.12mol、収率48.6%)。Elemental analysis (% by weight) Calculated value C: 57.64, H: 10.14, N: 3.20, P: 7.08 Actual value C: 57.60, H: 10.19, N: 3.07, P: 6.99 Example 3 Mono (2-octyldodecyl) Phosphoric acid 100.0 g (0.2
6 mol) and thionyl chloride 79.8 g (0.67 mol) were reacted in the same manner as in Example 1 to obtain dichlorophosphoridate. This was mixed with 84.0 g (0.65 mol) of quinoline, and the resulting solution was added dropwise at 0 ° C. to chloroform containing 107.8 g (0.31 mol) of benzyl-N-benzyloxycarbonylserine. By the same method as in Example 1, 58.8 g of the desired white solid of 2-amino-2-carboxyethyl-2-octyldodecylphosphate was obtained (0.12 mol, yield 48.6%).
元素分析(重量%) 計算値 C:59.33、H:10.39、N:3.01、P:6.65 実測値 C:59.27、H:10.39、N:2.96、P:6.43 実施例4 モノ(2−エチルテトラエイコシル)リン酸100.0g
(0.26mol)とチオニルクロライド99.5g(0.84m
ol)から実施例1と同様の方法によりジクロロホスホリ
デートを得たのち、キノリン72.5g(0.60mol)及
びベンジル−N−ベンジルオキシカルボニルセリン12
0.9g(0.35mol)を用い以下実施例1と同様の方法
により目的とする87.5gの2−アミノ−2−カルボキ
シエチル−2−エチルテトラエイコシルリン酸の白色固
体を得た(0.16mol、収率61.2%)。Elemental analysis (% by weight) Calculated value C: 59.33, H: 10.39, N: 3.01, P: 6.65 Measured value C: 59.27, H: 10.39, N: 2.96, P: 6.43 Example 4 Mono (2-ethyltetraeico) Sil) phosphoric acid 100.0 g
(0.26 mol) and thionyl chloride 99.5 g (0.84 m)
ol) was obtained in the same manner as in Example 1 to obtain dichlorophosphoridate, and then quinoline 72.5 g (0.60 mol) and benzyl-N-benzyloxycarbonylserine 12 were obtained.
Using 0.5 g (0.35 mol) of the same procedure as in Example 1 below, 87.5 g of the desired white solid of 2-amino-2-carboxyethyl-2-ethyltetraeicosylphosphate was obtained ( 0.16 mol, yield 61.2%).
元素分析の結果は以下の通りであった。The results of elemental analysis were as follows.
元素分析(重量%) 計算値 C:63.36、H:11.00、N:2.55、P:5.63 実測値 C:63.26、H:10.89、N:2.53、P:5.52 実施例5 モノ(2−ヒドロキシ−3−ラウリルオキシプロピル)
リン酸100.0g(0.29mol)と105.0g(0.88m
ol)のチオニルクロライドを用いてジクロロホスホリデ
ートを得た後、55.4g(0.70mol)のピリジンとベ
ンジル−N−ベンジルオキシカルボニルセリン179.6
g(0.52mol)を100mのクロロホルムに溶解さ
せ0℃で4時間攪拌し、その後室温にまで反応温度を上
げ4時間攪拌する。反応終了後、100mの水を加え
20℃で1時間攪拌する。その後溶媒を留去しジエチル
エーテルで抽出する。得られた残渣をメタノールに溶解
しパラジウム/炭素触媒を用いて常圧下メタノール加熱
還流下水素をふきこみ約10時間反応させる。反応終了
後メタノールを留去し得られた残渣をシリカゲルカラム
クロマトグラフィー(展開溶媒/クロロホルム:メタノ
ール=90:10)で精製することにより目的とする2
−アミノ−2−カルボキシエチル−(2−ヒドロキシ−
3−ラウリルオキシプロピル)リン酸の白色固体を39.
7g得た(0.09mol、収率32.0%)。Elemental analysis (% by weight) Calculated value C: 63.36, H: 11.00, N: 2.55, P: 5.63 Actual value C: 63.26, H: 10.89, N: 2.53, P: 5.52 Example 5 Mono (2-hydroxy-3) -Lauryloxypropyl)
Phosphoric acid 100.0 g (0.29 mol) and 105.0 g (0.88 m)
ol) thionyl chloride to obtain dichlorophosphoridate, and then 55.4 g (0.70 mol) of pyridine and benzyl-N-benzyloxycarbonylserine 179.6
g (0.52 mol) is dissolved in 100 m of chloroform and stirred at 0 ° C. for 4 hours, then the reaction temperature is raised to room temperature and stirred for 4 hours. After completion of the reaction, 100 m of water is added and the mixture is stirred at 20 ° C. for 1 hour. After that, the solvent is distilled off and the residue is extracted with diethyl ether. The obtained residue is dissolved in methanol, and hydrogen is bubbled in while heating and refluxing methanol under atmospheric pressure using a palladium / carbon catalyst and reacted for about 10 hours. After completion of the reaction, methanol was distilled off, and the obtained residue was purified by silica gel column chromatography (developing solvent / chloroform: methanol = 90: 10) to obtain the target 2
-Amino-2-carboxyethyl- (2-hydroxy-
The white solid of 3-lauryloxypropyl) phosphoric acid 39.
7 g was obtained (0.09 mol, yield 32.0%).
元素分析の結果は以下の通りであった。The results of elemental analysis were as follows.
元素分析(重量%) 計算値 C:50.58、H:8.96、N:3.28、P:7.24 実測値 C:50.55、H:8.92、N:3.25、P:7.18 実施例6 モノテトラオキシエチレンモノラウリルエーテルリン酸
100.0g(0.25mol)とチオニルクロライド90.5
g(0.76mol)からジクロロホスホリデートを得た。
その後ベンジル−N−ベンジルオキシカルボニルセリン
103.6g(0.30mol)とキノリン90.4g(0.70m
ol)を用いて以下実施例1と同様にして43.6gの2−
アミノ−2−カルボキシルエチル−テトラオキシエチレ
ンモノラウリルエーテルリン酸の白色固体を得た(0.0
8mol、収率32.9%)。Elemental analysis (wt%) Calculated value C: 50.58, H: 8.96, N: 3.28, P: 7.24 Actual value C: 50.55, H: 8.92, N: 3.25, P: 7.18 Example 6 monotetraoxyethylene monolauryl ether Phosphoric acid 100.0 g (0.25 mol) and thionyl chloride 90.5
Dichlorophosphoridate was obtained from g (0.76 mol).
Thereafter, 103.6 g (0.30 mol) of benzyl-N-benzyloxycarbonylserine and 90.4 g (0.70 m) of quinoline.
in the same manner as in Example 1, except that 43.6 g of 2-
A white solid of amino-2-carboxylethyl-tetraoxyethylene monolauryl ether phosphoric acid was obtained (0.0.
8 mol, yield 32.9%).
元素分析の結果は以下の通りであった。The results of elemental analysis were as follows.
元素分析(重量%) 計算値 C:52.16、H:9.14、N:2.64、P:5.85 実測値 C:52.01、H:9.13、N:2.61、P:5.73 実施例7 オクタデシルオキシエチレンモノラウリルエーテルリン
酸100.0g(0.094mol)とチオニルクロライド3
3.7g(0.28mol)からジクロロホスホリデートを得
た。その後ベンジル−N−ベンジルオキシカルボニルセ
リン46.6g(0.14mol)とピリジン22.4g(0.2
8mol)を用いて以下実施例1と同様にして17.3gの
2−アミノ−2−カルボキシルエチル−オクタデシルオ
キシエチレンモノラウリルエーテルリン酸の白色固体を
得た(0.015mol、収率16.0%)。Elemental analysis (% by weight) Calculated value C: 52.16, H: 9.14, N: 2.64, P: 5.85 Measured value C: 52.01, H: 9.13, N: 2.61, P: 5.73 Example 7 Octadecyloxyethylene monolauryl ether phosphorus Acid 100.0 g (0.094 mol) and thionyl chloride 3
Dichlorophosphoridate was obtained from 3.7 g (0.28 mol). After that, benzyl-N-benzyloxycarbonylserine 46.6 g (0.14 mol) and pyridine 22.4 g (0.2
8 mol) was used in the same manner as in Example 1 below to obtain 17.3 g of 2-amino-2-carboxylethyl-octadecyloxyethylene monolauryl ether phosphoric acid white solid (0.015 mol, yield 16.0). %).
元素分析の結果は以下の通りであった。The results of elemental analysis were as follows.
元素分析(重量%) 計算値 C:53.44、H:9.14、N:1.22、P:2.70 実測値 C:53.28、H:9.02、N:1.19、P:2.73 実施例8 2−ヒドロキシヘキサデシルリン酸100.0g(0.30
mol)とチオニルクロライド105.5g(0.89mol)か
らジクロロホスホリデートを得た。その後ベンジル−N
−ベンジルオキシカルボニルセリン146.0g(0.44
mol)とピリジン70.1g(0.89mol)を用いて以下実
施例1と同様にして24.6gの2−アミノ−2−カルボ
キシルエチル−2−ヒドロキシヘキサデシルリン酸の白
色固体を得た(0.058mol、収率19.6%)。Elemental analysis (% by weight) Calculated value C: 53.44, H: 9.14, N: 1.22, P: 2.70 Actual value C: 53.28, H: 9.02, N: 1.19, P: 2.73 Example 8 2-hydroxyhexadecylphosphate 100.0 g (0.30
mol) and 105.5 g (0.89 mol) of thionyl chloride to obtain dichlorophosphoridate. Then benzyl-N
-Benzyloxycarbonylserine 146.0 g (0.44
mol) and 70.1 g (0.89 mol) of pyridine and in the same manner as in Example 1 below, 24.6 g of 2-amino-2-carboxyethyl-2-hydroxyhexadecylphosphate white solid was obtained ( (0.058 mol, yield 19.6%).
元素分析の結果は以下の通りであった。The results of elemental analysis were as follows.
元素分析(重量%) 計算値 C:53.63、H:9.48、N:3.29、P:7.28 実測値 C:53.48、H:9.45、N:3.35、P:7.19 実施例9 モノヘプタデカフルオロデシルリン酸100.0g(0.1
8mol)とチオニルクロライド64.3g(0.54mol)か
らジクロロホスホリデートを得た。その後ベンジル−N
−ベンジルオキシカルボニルセリン86.3g(0.26mo
l)とピリジン42.4g(0.54mol)を用いて以下実施
例1と同様にして17.6gの2−アミノ−2−カルボキ
シエチル−ヘプタデカフルオロデシルリン酸の白色固体
を得た(0.028mol、収率15.4%)。Elemental analysis (% by weight) Calculated value C: 53.63, H: 9.48, N: 3.29, P: 7.28 Measured value C: 53.48, H: 9.45, N: 3.35, P: 7.19 Example 9 Monoheptadecafluorodecylphosphate 100.0 g (0.1
Dichlorophosphoridate was obtained from 8 mol) and 64.3 g (0.54 mol) of thionyl chloride. Then benzyl-N
-Benzyloxycarbonyl serine 86.3g (0.26mo
l) and pyridine 42.4 g (0.54 mol) were used in the same manner as in Example 1 to obtain 17.6 g of 2-amino-2-carboxyethyl-heptadecafluorodecylphosphoric acid white solid (0 0.028 mol, yield 15.4%).
元素分析の結果は以下の通りであった。The results of elemental analysis were as follows.
元素分析(重量%) 計算値 C:24.72、H:1.74、N:2.22、P:4.91、 F:51.19 実測値 C:24.65、H:1.77、N:2.29、P:4.95、 F:51.10 試験例1 実施例1に於いて合成した2−アミノ−2−カルボキシ
エチル−ラウリルリン酸のモノナトリウム塩を用いて下
記組成からなるスキンクリームを調整した。中性ないし
は弱酸性のクリームであって、乳化状態は良好でべとつ
きもなくなじみのよいクリームであった。Elemental analysis (wt%) Calculated value C: 24.72, H: 1.74, N: 2.22, P: 4.91, F: 51.19 Actual value C: 24.65, H: 1.77, N: 2.29, P: 4.95, F: 51.10 Test example 1 A skin cream having the following composition was prepared using the monosodium salt of 2-amino-2-carboxyethyl-lauryl phosphoric acid synthesized in Example 1. It was a neutral or weakly acidic cream, and had a good emulsified state and was not sticky and had good compatibility.
スキンクリーム: 2−アミノ−2−カルボキシエチル−ラウリルリン酸 1.2(重量%) モノステアリン酸グリセリン 2.4 セタノール 4.0 固型パラフィン 5.0 スクワラン 10.0 ミリスチン酸オクチルドデシル 6.0 グリセリン 6.0 香料、色素、防腐剤 適量 イオン交換水 バランスSkin cream: 2-amino-2-carboxyethyl-lauryl phosphate 1.2 (% by weight) Glycerin monostearate 2.4 Cetanol 4.0 Solid paraffin 5.0 Squalane 10.0 Octyldodecyl myristate 6.0 Glycerin 6.0 Fragrance, dye, preservative A suitable amount of ion-exchanged water balance
第1図は実施例1で得られた2−アミノ−2−カルボキ
シエチル−ラウリルリン酸の1H-NMRスペクトルを示す図
面である。第2図は同化合物のIRスペクトルを示す図面
である。FIG. 1 is a drawing showing the 1 H-NMR spectrum of 2-amino-2-carboxyethyl-lauryl phosphate obtained in Example 1. FIG. 2 is a drawing showing the IR spectrum of the same compound.
Claims (2)
素原子がフッ素原子で置換されていてもよいアルキル基
を、R5は水素原子、メチル基またはエチル基を、nは0
〜20の数を示す) で表わされるR2かまたは次式(III) (式中、R6はR7またはOR8で示され、R7、R8は炭素数8
〜36の直鎖または分岐鎖の、水素原子がフッ素原子で
置換されていてもよいアルキル基を示す) で表わされるR3を示し、M1及びM2は同じかまたは異なっ
て水素原子、アルカリ金属、またはアルカノールアミン
塩若しくはアンモニウム塩であることを示す〕 で表わされるリン酸エステル。1. The following formula (I) (Wherein, R 1 is the following formula (II) (In the formula, R 4 is a linear or branched alkyl group having 8 to 36 carbon atoms in which a hydrogen atom may be substituted with a fluorine atom, R 5 is a hydrogen atom, a methyl group or an ethyl group, and n is Is 0
R 2 or the formula represented by 20 the number of) (III) (In the formula, R 6 is represented by R 7 or OR 8 , and R 7 and R 8 have 8 carbon atoms.
~ 36 straight-chain or branched, which represents an alkyl group in which a hydrogen atom may be substituted with a fluorine atom) R 3 is represented by, and M 1 and M 2 are the same or different and each is a hydrogen atom, an alkali. A metal, or an alkanolamine salt or an ammonium salt].
素原子がフッ素原子で置換されていてもよいアルキル基
を、R5は水素原子、メチル基またはエチル基を、nは0
〜20の数を示す) で表わされるR2かまたは次式(III) (式中、R6はR7またはOR8で示され、R7、R8は炭素数8
〜36の直鎖または分岐鎖の、水素原子がフッ素原子で
置換されていてもよいアルキル基を示す) で表わされるR3を示す〕 で表わされるモノアルキルリン酸の水酸基をハロゲン化
した後、次式(V) で表わされるN−ベンジルオキシカルボニルセリンエス
テルと反応させ、次いでカルボキシル基及びアミノ基の
保護基を除去することを特徴とする次式(I) 〔式中、M1及びM2は同じかまたは異なって水素原子、ア
ルカリ金属、またはアルカノールアミン塩若しくはアン
モニウム塩であることを示し、R1は前記と同じ〕 で表わされるリン酸エステルの製造方法。2. The following formula (IV) (Wherein, R 1 is the following formula (II) (In the formula, R 4 is a linear or branched alkyl group having 8 to 36 carbon atoms in which a hydrogen atom may be substituted with a fluorine atom, R 5 is a hydrogen atom, a methyl group or an ethyl group, and n is Is 0
R 2 or the formula represented by 20 the number of) (III) (In the formula, R 6 is represented by R 7 or OR 8 , and R 7 and R 8 have 8 carbon atoms.
To 36 of a linear or branched, hydrogen atom of the monoalkyl phosphoric acid represented by the formula ( 3 ), which represents an alkyl group in which a hydrogen atom may be substituted with a fluorine atom). Formula (V) The following formula (I) is characterized by reacting with N-benzyloxycarbonylserine ester represented by the following formula, and then removing protecting groups for carboxyl group and amino group. [Wherein, M 1 and M 2 are the same or different and each represents a hydrogen atom, an alkali metal, or an alkanolamine salt or an ammonium salt, and R 1 is the same as the above]. .
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/925,384 US4751320A (en) | 1985-11-27 | 1986-10-31 | Phosphoric ester and process for producing same |
GB8627271A GB2183653B (en) | 1985-11-27 | 1986-11-14 | A phosphoric ester and process for producing the same |
DE19863639084 DE3639084A1 (en) | 1985-11-27 | 1986-11-14 | PHOSPHORIC ACID ESTERS AND METHOD FOR THE PRODUCTION THEREOF |
FR868616211A FR2593505B1 (en) | 1985-11-27 | 1986-11-21 | PHOSPHORIC ESTER SUBSTITUTED BY SERINE AND ITS MANUFACTURING METHOD |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60-266486 | 1985-11-27 | ||
JP26648685 | 1985-11-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62201892A JPS62201892A (en) | 1987-09-05 |
JPH064651B2 true JPH064651B2 (en) | 1994-01-19 |
Family
ID=17431602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61181653A Expired - Lifetime JPH064651B2 (en) | 1985-11-27 | 1986-08-01 | Phosphate ester and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH064651B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0413700A1 (en) * | 1988-04-19 | 1991-02-27 | Hafslund Nycomed Pharma Aktiengesellschaft | New alkylphosphono- and phosphoserines, method for preparing them, and pharmaceutical substances containing them |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT339397B (en) * | 1974-11-19 | 1977-10-10 | Evg Entwicklung Verwert Ges | METHOD AND DEVICE FOR MANUFACTURING ELECTRICAL CONDUCTORS WITH CONSTANT OHMS RESISTANCE PER LENGTH UNIT |
JPS57204611U (en) * | 1981-06-24 | 1982-12-27 |
-
1986
- 1986-08-01 JP JP61181653A patent/JPH064651B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS62201892A (en) | 1987-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0228612B1 (en) | A derivative of alpha, alpha-trehalose and a process for preparing the same | |
EP0036583B1 (en) | Glycerine-3-phosphoric acid halogenalkyl ester, process for its preparation and further processing | |
JP3102798B2 (en) | Inositol derivatives, formulations containing them and their use | |
US4751320A (en) | Phosphoric ester and process for producing same | |
DE69631542T2 (en) | NEW GERANYLGERANYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND RELATED PHARMACEUTICAL COMPOSITIONS | |
JP2614149B2 (en) | New alkyl phosphate | |
US4163748A (en) | Propane-1,3-diol phosphatides and method of preparing the same | |
JPH0246039B2 (en) | ||
US4916249A (en) | Glycero-3(2)-phospho-L-serine derivatives and salts thereof | |
JPH064651B2 (en) | Phosphate ester and method for producing the same | |
JP2683473B2 (en) | Novel sterin derivative and method for producing the same | |
JPS63135395A (en) | Phospholipid derivative and production thereof | |
EP0043472B1 (en) | 3-hydrocarbylthio-2-acyloxypropyl 2-trimethylammonioethyl phosphates, process for producing the same and pharmaceutical preparations containing the same | |
US4740609A (en) | Phosphoric esters and process for preparing same | |
EP0229128B1 (en) | Derivatives of glycero-3(2)-phospho-l-serine and pharmaceutical preparations containing them | |
JPH0327556B2 (en) | ||
US4160773A (en) | Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use | |
US4517297A (en) | Method for the preparation of physiological effectors | |
EP0663918A1 (en) | Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors | |
JPS6188886A (en) | Preparation of phospholipid long-chain alcohol derivative by enzymatic process | |
US5117034A (en) | Phosphatidylserine derivatives | |
JP3171279B2 (en) | Method for producing alkylphosphocholine having 14 to 18 carbon atoms and method for purifying alkylphosphocholine | |
SU653264A1 (en) | Method of obtaining incomplete ethers of phosphorus-substituted methyl-phosphonium acid | |
JP3619277B2 (en) | Method for producing dihydropolyprenyl monophosphate and its intermediate compound | |
JP3529843B2 (en) | Method for producing aromatic phospholipid derivative |